Cancer Biotherapy and Radiopharmaceuticals · 2013 · 45 citations · 16 references
MedicineOncologyPathologyGene ExpressionMetastasisMolecular OncologyBreast PathologyLymph Node MetastasisMetastatic Breast CancerBreast Cancer Metastasis To Lymph NodesBreast Cancer PrognosisCancer Metastasis BiomarkersClinicopathological CorrelationLymph Node Metastasis BiomarkersLymphatic Metastasis BiomarkersMicrorna BiomarkersMicrorna In Cancer
PURPOSE: The aim of this study was to investigate the relationship between the expressions of microRNA-9 (miR-9) and microRNA-200c (miR-200c) in human breast cancers and clinicopathological features. METHODS: We investigated the expressions of miR-9 and miR-200c in 68 patients with breast cancers using the quantitative reverse transcription-polymerase chain reaction method, and assessed the E-cadherin status using the immunohistochemistry method. RESULTS: The relative expression levels of miR-9 and miR-200c in breast cancer patients with lymph node metastasis were higher than that of patients without lymph node metastasis. The expression of miR-9 correlated inversely with E-cadherin expression. CONCLUSIONS: The results showed that higher expressions of miR-9 and miR-200c in human breast cancers were associated with lymph node metastasis. This study indicated that the elevation of miR-9 and miR-200c in human breast cancers can induce an invasive phenotype and may serve as a molecular diagnostic marker for patients with breast cancer.
16
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Marilena V. Iorio, Manuela Ferracin, Chang‐Gong Liu et al. · Cancer Research · 2005 · 4.1K citations
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Li Ma, Jennifer J. Young, Harsha Prabhala et al. · Nature Cell Biology · 2010 · 1.3K citations · Full text